Neurotherapeutics Ltd
13198315
Some Concerns
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2025
total exemption full
Next accounts due
30/09/2027
Confirmation statement
Last: 10/02/2026
Due 24/02/2027
Industry
Officers
Paul Michael Cable
director · Since 31/01/2023
British
Georgina Margaret Jackson
director · Since 12/02/2021
British
Barbara Morera Maiquez
director · Since 01/12/2022
Spanish
Karl Moss
director · Since 01/09/2024
British
David John O'Reilly
director · Since 01/09/2024
American
Ian Rhodes
director · Since 01/01/2022
British
Former
James Stuart Duncan
director · Resigned 21/02/2024
Stephen Raymond Jackson
director · Resigned 28/02/2024
Andrew Paul Mcneill
director · Resigned 16/03/2026
CompanyRankvs 105+ SIC 26600 peers66
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
tion and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going
Key FinancialsYear ending 31/12/2025
Net Worth
£1.1M
Balance sheet strength
Cash
£947k
Cash in the bank
Net Current Assets
£966k
Working capital
Current Assets
£1.2M
Current Liabilities
£246k
Fixed Assets
£109k
Debtors
£251k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2025 | 4.92 | -£1.1M | £3k |
| 2024 | 21.51 | — | — |
Derived from filed accounts. Not audited figures.